QQ客服 官方微博 反馈留言

	EXPAND, a dose-finding study of ruxolitinib in patients with myelofibrosis and low platelet counts: 48-week follow-up analysis
	Vannucchi, Alessandro M.; te Boekhorst, Peter A. W.; Harrison, Claire N.; He, Guangsheng; Caramella, Marianna; Niederwieser, Dietger; Boyer-Perrard, Francoise; Duan, Minghui; Francillard, Nathalie; Molloy, Betty
	2019
卷号	104期号:5页码:947-954
关键词	Chronic Myeloproliferative Disorders myelofibrosis ruxolitinib
ISSN号	0390-6078
DOI	10.3324/haematol.2018.204602
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6345757
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Vannucchi, Alessandro M.,te Boekhorst, Peter A. W.,Harrison, Claire N.,et al. EXPAND, a dose-finding study of ruxolitinib in patients with myelofibrosis and low platelet counts: 48-week follow-up analysis[J],2019,104(5):947-954.
APA	Vannucchi, Alessandro M..,te Boekhorst, Peter A. W..,Harrison, Claire N..,He, Guangsheng.,Caramella, Marianna.,...&Gisslinger, Heinz.(2019).EXPAND, a dose-finding study of ruxolitinib in patients with myelofibrosis and low platelet counts: 48-week follow-up analysis.,104(5),947-954.
MLA	Vannucchi, Alessandro M.,et al."EXPAND, a dose-finding study of ruxolitinib in patients with myelofibrosis and low platelet counts: 48-week follow-up analysis".104.5(2019):947-954.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。